Newsroom
Securities Fraud Lawsuits Filed Against MacroGenics, Inc. by Multiple Law Firms
By KlickAnalytics Data Insights | August 1, 2024 08:02PM ET
Key Points
- Various law firms have filed class action lawsuits against MacroGenics, Inc. for securities fraud.
- The lawsuits cover the period between March 7, 2024, and May 9, 2024.
- Investors who suffered losses during this period can potentially recover under federal securities laws.
- The lead plaintiff deadline for these lawsuits is September 24, 2024.
- Investors are urged to contact the respective law firms to discuss their rights.
Multiple law firms have taken action against MacroGenics, Inc. (NASDAQ:MGNX) by filing class action lawsuits for securities fraud. The lawsuits cover the period between March 7, 2024, and May 9, 2024, during which investors may have incurred losses.
The law firms involved include Levi & Korsinsky, Rosen Law Firm, Pomerantz Law Firm, Bronstein, Gewirtz & Grossman LLC, Kessler Topaz Meltzer & Check, LLP, and The Schall Law Firm. These firms are actively seeking investors who have suffered financial losses during the specified timeframe to potentially recover under federal securities laws.
Investors who believe they may have a claim are encouraged to contact the respective law firms before the lead plaintiff deadline of September 24, 2024. By doing so, investors can discuss their rights and explore potential avenues for recovery. The lawsuits aim to hold MacroGenics, Inc. accountable for alleged violations of federal securities laws.
If you are an investor who lost money on your MacroGenics, Inc. investment during the aforementioned period, it is essential to act promptly and reach out to the law firms mentioned to assess your options. The legal teams are dedicated to assisting investors in seeking justice and potential restitution for any damages suffered.
For more information:
Ask the market a question. Get a calculated answer.
The AI is not a chatbot bolted onto a document store. It calls the same analytics engine that powers every screen on this platform — so what comes back is a number it computed from raw history, with the command that produced it.
86,000+ instruments
Global equities, ETFs, funds, options, FX, commodities, crypto, economics, filings, transcripts and news — one normalised symbol universe with adjusted history.
A real analytics engine
Screening, backtesting, technicals, options analytics, correlations, seasonality and factor models — computed on demand from raw prices, never a stale cache.
It shows its working
Answers arrive with the charts, tables and tool calls behind them, so you can check the number instead of trusting a paraphrase.
Your own documents
Upload filings, decks and research. Ask across them and the answer cites the page it came from.
Agents and workflows
Multi-step research that runs the platform's tools for you — screen, pull the history, compute, compare, then write it up.
MCP, CLI and API
The same command catalogue from Claude, your own agent, a shell or your pipeline. The answer on screen is the answer your job gets at 4am.
You ask
“How does NVDA usually trade through earnings?”
It calls
→ ka.options_expected_move(NVDA)
It answers
NVDA has averaged a 9.2% absolute move on the day after earnings and closed higher 67% of the time. Two in three reactions land between −4.2% and +16.3% — the distribution is skewed right, not symmetric.
Every figure computed live from our own history — not scraped, not summarised.
Or start with